Cargando…
New paradigms for understanding and step changes in treating active and chronic, persistent apicomplexan infections
Toxoplasma gondii, the most common parasitic infection of human brain and eye, persists across lifetimes, can progressively damage sight, and is currently incurable. New, curative medicines are needed urgently. Herein, we develop novel models to facilitate drug development: EGS strain T. gondii form...
Autores principales: | McPhillie, Martin, Zhou, Ying, El Bissati, Kamal, Dubey, Jitender, Lorenzi, Hernan, Capper, Michael, Lukens, Amanda K, Hickman, Mark, Muench, Stephen, Verma, Shiv Kumar, Weber, Christopher R., Wheeler, Kelsey, Gordon, James, Sanders, Justin, Moulton, Hong, Wang, Kai, Kim, Taek-Kyun, He, Yuqing, Santos, Tatiana, Woods, Stuart, Lee, Patty, Donkin, David, Kim, Eric, Fraczek, Laura, Lykins, Joseph, Esaa, Farida, Alibana-Clouser, Fatima, Dovgin, Sarah, Weiss, Louis, Brasseur, Gael, Wirth, Dyann, Kent, Michael, Hood, Leroy, Meunieur, Brigitte, Roberts, Craig W., Hasnain, S. Samar, Antonyuk, Svetlana V., Fishwick, Colin, McLeod, Rima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944145/ https://www.ncbi.nlm.nih.gov/pubmed/27412848 http://dx.doi.org/10.1038/srep29179 |
Ejemplares similares
-
Author Correction: New paradigms for understanding and step changes in treating active and chronic, persistent apicomplexan infections
por: McPhillie, Martin, et al.
Publicado: (2020) -
Potent Tetrahydroquinolone Eliminates Apicomplexan Parasites
por: McPhillie, Martin J., et al.
Publicado: (2020) -
The potential use of single-particle electron microscopy as a tool for structure-based inhibitor design
por: Rawson, S., et al.
Publicado: (2017) -
CSGID Solves Structures and Identifies Phenotypes for Five Enzymes in Toxoplasma gondii
por: Lykins, Joseph D., et al.
Publicado: (2018) -
Developments in Non-Intercalating Bacterial Topoisomerase Inhibitors: Allosteric and ATPase Inhibitors of DNA Gyrase and Topoisomerase IV
por: Grossman, Scott, et al.
Publicado: (2023)